Abstract:Introduction Deep vein thrombosis (DVT) poses a complex challenge and often leads to postthrombotic syndrome (PTS), a debilitating complication. The emergence of venous stents offers a potential preventive avenue against this complication. This study aimed to provide consensus recommendations on the use of venous stent for DVT. Materials and Methods From June to July 2023, 20 internal medicine, angiology and vascular surgery, and vascular and interventional radiology experts were involved in the Delphi process. Thirty-one recommendations, categorized into three thematic areas, were rigorously evaluated: indications for stent use, stent selection and placement, and monitoring and prevention of complications. Agreement was evaluated using a Likert scale, with consensus defined as agreement by two-thirds of the participants. Results Consensus was reached for 23 (74.2%) of 31 recommendations. The agreement was centered on considerations, such as stent placement in specific acute DVT scenarios, emphasizing pivotal stent characteristics. However, there were divergences in the recommended stent length to prevent migration and stent characteristics based on iliocaval bifurcation morphology. Notably, there was no consensus on whether patients with DVT caused by a major transient risk factor need more than 3 months of anticoagulation therapy or whether aspirin should be added to anticoagulant treatment after venous stenting. Conclusions These consensus recommendations offer practical insights into optimizing venous stent use to prevent PTS in DVT patients. Addressing the critical aspects of stent selection, placement, and postprocedural care, these recommendations contribute to clinical decision-making. The identified divergences underscore the importance of consensus and thus indicate the need for further investigation. Borja Castejón Navarro (Complejo hospitalario Ruber Juan Bravo, Madrid, Spain); Eduardo Crespo Vallejo (Fundación Jiménez Díaz, Madrid, Spain); Eva Criado Paredes (Corporació Sanitària Parc Taulí, Barcelona, Spain); Juan Fontcuberta García (Hospital de La Zarzuela, Hospital de la Moraleja, Madrid, Spain); Francisco Galeano Valle (Hospital Universitario Gregorio Marañón, Madrid, Spain); Íñigo Insausti Gorbea (Clínica Universitaria de Navarra, Pamplona, Spain); Luis Izquierdo Lamoca (Hospital Universitario HM Puerta del Sur, Madrid, Spain); Juan José López Núñez (Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain); Alicia Lorenzo Hernández (Hospital Universitario La Paz, Madrid, Spain); Ana Maestre Peiró (Hospital Universitario de Vinalopó, Elche Alicante); Oscar Merino Mairal (Clínica Rotger Quironsalud, Palma, Spain); Manuel Jesús Núñez Fernández (Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain; Sonia del Pilar Otalora Valderrama (Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain); Maria Luisa Robles Martín (Hospital Quirónsalud, Málaga, Spain); Ruben Rodríguez Carvajal (Hospital Quirónsalud Campo de Gibraltar, Cádiz, Spain). Article published online: 11 May 2024 © 2024. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

Principles of Optimal Antithrombotic Therapy for Iliac VEnous Stenting (POATIVES): A national Expert Based Delphi Consensus Study

[Antithrombotic therapy after iliac vein stenting].

Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis

Prescribing Patterns of Antithrombotic Therapy for Lower Extremity Endovascular Procedures and Venous Thromboembolism Management in Mainland China

Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: A multicenter study with propensity score matching

Optimal Medical Therapy Following Deep Venous Interventions: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel

A DELPHI consensus statement on antiplatelet management for intracranial stenting due to underlying atherosclerosis in the setting of mechanical thrombectomy

Antithrombotic management of patients with deep vein thrombosis and venous stents: an international registry

Stent Patency Rates and Prognostic Factors of Endovascular Intervention for Iliofemoral Vein Occlusion in Post-Thrombotic Syndrome.

Review of the literature supporting international clinical practice guidelines on iliac venous stenting and their applicability to Australia and New Zealand practice

Antithrombotic Therapy after Deep Venous Intervention

The Beneficial Role of Intravascular Ultrasound in the Diagnosis and Treatment of Nonthrombotic Iliac Venous Obstructions As Compared with Traditional Venography in the Chinese Population

Treatment of Femoral Vein Obstruction Concomitant with Iliofemoral Stenting in Patients with Severe Post-thrombotic Syndrome.

Omission of Aspirin in Patients Taking Oral Anticoagulation after Percutaneous Coronary Intervention: a Systematic Review and Meta-Analysis

PRINciples of optimal antithrombotiC therapy and coagulation managEment during elective fenestrated and branched EndovaScular aortic repairS (PRINCE2SS): an international expert-based Delphi consensus study.

Prophylaxis of deep venous thrombosis and adherence to guideline recommendations among inpatients with acute stroke: results from a multicenter observational longitudinal study in China.

Reducing the Risk of Venous Thromboembolism Following Superficial Endovenous Treatment: A UK and Republic of Ireland Consensus Study

Antiplatelet Therapy is Associated with Stent Patency After Iliocaval Venous Stenting

Expert Consensus on the Clinical Application of Totally Implantable Venous Access Devices in the Upper Arm (2022 Edition)

Three-Year Outcomes, Risk Factors for Restenosis After Stenting for DVT Combined with Iliac Vein Compression Syndrome

Pivotal Evaluation of Novel Dedicated Venous Stent for Iliofemoral Venous Obstruction: A Prospective Cohort Study